Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis

키워드

참고문헌 (93)

1. Rawlins ML, "Performance characteristics of six third-generation assays for thyroid-stimulating hormone", Clin Chem, 50, pp.2338~2344 (2004)
2. La’ulu SL, "Performance characteristics of five automated CA 19-9 assays", Am J Clin Pathol, 127, pp.436~440 (2007)
3. Goodman SL, "The antibody horror show: an introductory guide for the perplexed", N Biotechnol, 45, pp.9~13 (2018)
4. O’Kennedy R, "Antibody engineering: an overview", Essays Biochem, 26, pp.59~75 (1991)
5. Hamers-Casterman C, "Naturally occurring antibodies devoid of light chains", Nature, 363, pp.446~448 (1993)
6. Greenberg AS, "A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks", Nature, 374, pp.168~173 (1995)
7. Roux KH, "Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins", Proc Natl Acad Sci U S A, 95, pp.11804~11809 (1998)
8. Nguyen VK, "Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies", Mol Immunol, 36, pp.515~524 (1999)
9. Woolven BP, "The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation", Immunogenetics, 50, pp.98~101 (1999)
10. van der Linden R, "Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama", J Immunol Methods, 240, pp.185~195 (2000)
11. Vu KB, "Comparison of llama VH sequences from conventional and heavy chain antibodies", Mol Immunol, 34, pp.1121~1131 (1997)
12. Harmsen MM, "Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features", Mol Immunol, 37, pp.579~590 (2000)
13. Decanniere K, "Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?", J Mol Biol, 300, pp.83~91 (2000)
14. Muyldermans S, "Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains", Protein Eng, 7, pp.1129~1135 (1994)
15. Muyldermans S, "Nanobodies: natural single-domain antibodies", Annu Rev Biochem, 82, pp.775~797 (2013)
16. Verheesen P, "Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation", Biochim Biophys Acta, 1764, pp.1307~1319 (2006)
17. Nguyen VK, "Functional heavy-chain antibodies in Camelidae", Adv Immunol, 79, pp.261~296 (2001)
18. van der Linden RH, "Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies", Biochim Biophys Acta, 1431, pp.37~46 (1999)
19. Arbabi Ghahroudi M, "Selection and identification of single domain antibody fragments from camel heavy-chain antibodies", FEBS Lett, 414, pp.521~526 (1997)
20. Abbady AQ, "Chaperonin GroEL a Brucella immunodominant antigen identified using Nanobody and MALDI-TOF-MS technologies", Vet Immunol Immunopathol, 146, pp.254~263 (2012)
21. Saerens D, "Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens", J Immunol Methods, 329, pp.138~150 (2008)
22. Sockolosky JT, "Durable antitumor responses to CD47 blockade require adaptive immune stimulation", Proc Natl Acad Sci U S A, 113, pp.E2646~E2654 (2016)
23. Dumoulin M, "Single-domain antibody fragments with high conformational stability", Protein Sci, 11, pp.500~515 (2002)
24. Lauwereys M, "Potent enzyme inhibitors derived from dromedary heavy-chain antibodies", EMBO J, 17, pp.3512~3520 (1998)
25. Desmyter A, "Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody", J Biol Chem, 276, pp.26285~26290 (2001)
26. Desmyter A, "Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme", Nat Struct Biol, 3, pp.803~811 (1996)
27. Ladenson RC, "Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment", Anal Chem, 78, pp.4501~4508 (2006)
28. Spinelli S, "Camelid heavy-chain variable domains provide efficient combining sites to haptens", Biochemistry, 39, pp.1217~1222 (2000)
29. Kijanka M, "Nanobody-based cancer therapy of solid tumors", Nanomedicine (Lond), 10, pp.161~174 (2015)
30. Vincke C, "General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold", J Biol Chem, 284, pp.3273~3284 (2009)
31. Klarenbeek A, "Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform", MAbs, 7, pp.693~706 (2015)
32. Zavrtanik U, "Structural basis of epitope recognition by heavy-chain camelid antibodies", J Mol Biol, 430, pp.4369~4386 (2018)
33. Muyldermans S, "A guide to: generation and design of nanobodies", FEBS J, 288, pp.2084~2102 (2021)
34. Fatima A, "Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis", PLoS One, 9, pp.e95263~ (2014)
35. Pinto Torres JE, "Development of a nanobody-based lateral flow assay to detect active Trypanosoma congolense infections", Sci Rep, 8, pp.9019~ (2018)
36. Fraile S, "NanoPad: an integrated platform for bacterial production of camel nanobodies aimed at detecting environmental biomarkers", Proteomics, 13, pp.2766~2775 (2013)
37. Zhang YQ, "Isolation of Bactrian camel single domain antibody for parathion and development of one-step dc-FEIA method using VHH-alkaline phosphatase fusion protein", Anal Chem, 90, pp.12886~12892 (2018)
38. Huo J, "Development of a highly sensitive direct competitive fluorescence enzyme immunoassay based on a nanobody-alkaline phosphatase fusion protein for detection of 3-phenoxybenzoic acid in urine", J Agric Food Chem, 66, pp.11284~11290 (2018)
39. Huo J, "Hapten synthesis, antibody development, and a highly sensitive indirect competitive chemiluminescent enzyme immunoassay for detection of dicamba", J Agric Food Chem, 67, pp.5711~5719 (2019)
40. Kim HJ, "Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay", Anal Chem, 84, pp.1165~1171 (2012)
41. Wang J, "Heterologous antigen selection of camelid heavy chain single domain antibodies against tetrabromobisphenol A", Anal Chem, 86, pp.8296~8302 (2014)
42. Zhang JR, "Development of a simple pretreatment immunoassay based on an organic solvent-tolerant nanobody for the detection of carbofuran in vegetable and fruit samples", Biomolecules, 9, pp.576~ (2019)
43. Li H, "A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin", Analyst, 139, pp.3718~3721 (2014)
44. Liu JL, "Improving biosensing activity to carcinoembryonic antigen with orientated single domain antibodies", Heliyon, 3, pp.e00478~ (2017)
45. Saerens D, "Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing", Anal Chem, 77, pp.7547~7555 (2005)
46. Liu X, "Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity", J Pharm Biomed Anal, 158, pp.361~369 (2018)
47. Bock JL, "How sensitive is a prostate-specific antigen measurement? How sensitive does it need to be?", Arch Pathol Lab Med, 128, pp.341~343 (2004)
48. Murad H, "Exploiting nanobodies in the detection and quantification of human growth hormone via phage-sandwich enzyme-linked immunosorbent assay", Front Endocrinol (Lausanne), 8, pp.115~ (2017)
49. Morales-Yánez F, "Fast one-step ultrasensitive detection of Toxocara canis antigens by a nanobody-based electrochemical magnetosensor", Anal Chem, 91, pp.11582~11588 (2019)
50. Morales-Yánez F, "Electrochemical detection of Toxocara canis excretory-secretory antigens in children from rural communities in Esmeraldas Province, Ecuador: association between active infection and high eosinophilia", Parasit Vectors, 13, pp.245~ (2020)
51. Vaneycken I, "Immuno-imaging using nanobodies", Curr Opin Biotechnol, 22, pp.877~881 (2011)
52. Hutt M, "Plasma half-life extension of small recombinant antibodies by fusion to immunoglobulin-binding domains", J Biol Chem, 287, pp.4462~4469 (2012)
53. Unverdorben F, "Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A", Protein Eng Des Sel, 25, pp.81~88 (2012)
54. Keyaerts M, "Phase I study of 68Ga-HER2-nanobody for PET", CT assessment of HER2 expression in breast carcinoma, 2016, pp.57, 27~33
55. Nuttall SD, "Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1", Proteins, 55, pp.187~197 (2004)
56. Obishakin E, "Generation of a nanobody targeting the paraflagellar rod protein of trypanosomes", PLoS One, 9, pp.e115893~ (2014)
57. Odongo S, "An anti-proteome nanobody library approach yields a specific immunoassay for Trypanosoma congolense diagnosis targeting glycosomal aldolase", PLoS Negl Trop Dis, 10, pp.e0004420~ (2016)
58. Pinto J, "Structural basis for the high specificity of a Trypanosoma congolense immunoassay targeting glycosomal aldolase", PLoS Negl Trop Dis, 11, pp.e0005932~ (2017)
59. Abeijon C, "Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis", Parasite Immunol, 40, pp.e12584~ (2018)
60. Barreto T, "Single-chain antibodies from alpaca for the detection of Fasciola hepatica antigens", Rev Peru Med Exp Salud Publica, 35, pp.573~580 (2018)
61. Deckers N, "Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis", Int J Parasitol, 39, pp.625~633 (2009)
62. Morales-Yanez FJ, "An innovative approach in the detection of Toxocara canis excretory", secretory antigens using specific nanobodies, 2019, pp.49, 635~645
63. Wang F, "Chemiluminescent enzyme immunoassay and bioluminescent enzyme immunoassay for tenuazonic acid mycotoxin by exploitation of nanobody and nanobody-nanoluciferase fusion", Anal Chem, 92, pp.11935~11942 (2020)
64. Riazi A, "Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens", PLoS One, 8, pp.e83928~ (2013)
65. Hussack G, "Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility", Protein Eng Des Sel, 27, pp.191~198 (2014)
66. Tu Z, "Identification and characterization of species-specific nanobodies for the detection of Listeria monocytogenes in milk", Anal Biochem, 493, pp.1~7 (2016)
67. Melli LJ, "Development and evaluation of a novel VHH-based immunocapture assay for high-sensitivity detection of Shiga toxin Type 2 (Stx2) in stool samples", J Clin Microbiol, 58, pp.e01566-19~ (2020)
68. Liu JL, "Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library", Mol Immunol, 44, pp.1775~1783 (2007)
69. Zhu M, "Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1", J Transl Med, 12, pp.352~ (2014)
70. Liu JL, "Selection of single-domain antibodies towards western equine encephalitis virus", Antibodies (Basel), 7, pp.44~ (2018)
71. Gelkop S, "The development and validation of a novel nanobody-based competitive ELISA for the detection of foot and mouth disease 3ABC antibodies in cattle", Front Vet Sci, 5, pp.250~ (2018)
72. Ma Z, "A novel biotinylated nanobody-based blocking ELISA for the rapid and sensitive clinical detection of porcine epidemic diarrhea virus", J Nanobiotechnology, 17, pp.96~ (2019)
73. Goodchild SA, "Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries", Mol Immunol, 48, pp.2027~2037 (2011)
74. Habib I, "V(H)H (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assays", Anal Biochem, 438, pp.82~89 (2013)
75. Chen J, "Nanobody medicated immunoassay for ultrasensitive detection of cancer biomarker alpha-fetoprotein", Talanta, 147, pp.523~530 (2016)
76. Schlör A, "Generation and validation of murine monoclonal and camelid recombinant single domain antibodies specific for human pancreatic glycoprotein 2", N Biotechnol, 45, pp.60~68 (2018)
77. Faraji F, "Development and characterization of a camelid single-domain antibody directed to human CD22 biomarker", Biotechnol Appl Biochem, 65, pp.718~725 (2018)
78. Li T, "Nanobody-based dual epitopes protein identification (DepID) assay for measuring soluble CD38 in plasma of multiple myeloma patients", Anal Chim Acta, 1029, pp.65~71 (2018)
79. Huang C, "Generation and application of fluorescent anti-human beta2-microglobulin VHH’s via amino modification", Molecules, 24, pp.2600~ (2019)
80. Gainkam LO, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy", Mol Imaging Biol, 13, pp.940~948 (2011)
81. Romão E, "Identification of nanobodies against the acute myeloid leukemia marker CD33", Int J Mol Sci, 21, pp.310~ (2020)
82. Movahedi K, "Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages", Cancer Res, 72, pp.4165~4177 (2012)
83. Blykers A, "PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18F-Radiolabeled camelid single-domain antibody fragments", J Nucl Med, 56, pp.1265~1271 (2015)
84. Evazalipour M, "Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer", Contrast Media Mol Imaging, 9, pp.211~220 (2014)
85. Krasniqi A, "Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma", Mol Cancer Ther, 16, pp.2828~2839 (2017)
86. Krasniqi A, "Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20", N Biotechnol, 45, pp.69~79 (2018)
87. Balhuizen A, "A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells", Sci Rep, 7, pp.15130~ (2017)
88. van Brussel AS, "Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast", Breast Cancer Res Treat, 140, pp.263~272 (2013)
89. Zheng F, "Molecular imaging with Kupffer cell-targeting nanobodies for diagnosis and prognosis in mouse models of liver pathogenesis", Mol Imaging Biol, 19, pp.49~58 (2017)
90. Zheng F, "Specificity evaluation and disease monitoring in arthritis imaging with complement receptor of the Ig superfamily targeting Nanobodies", Sci Rep, 6, pp.35966~ (2016)
91. Zheng F, "Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis", J Nucl Med, 55, pp.824~829 (2014)
92. Broisat A, "Nanobodies targeting mouse", human VCAM1 for the nuclear imaging of atherosclerotic lesions, 2012, pp.110, 927~937
93. Jailkhani N, "Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix", Proc Natl Acad Sci U S A, 116, pp.14181~14190 (2019)

관련 논문AI추천